Inflammation and Antiangiogenesis in Cancer

Title: Inflammation and Antiangiogenesis in Cancer

Volume: 19 Issue: 7

Author(s): D. Ribatti, E. Crivellato and A. Vacca

Affiliation:

Keywords: Angiogenesis, anti-angiogenesis, adaptive immunity, inflammation, innate immunity, lymphocytes, macrophages, mast cells, neutrophils, platelets, tumor progression

Abstract: The immune system regulates angiogenesis in cancer by means of pro- and anti-angiogenesis activities. In fact, both innate (macrophages, granulocytes, mast cells, dendritic cells, natural killer cells, and platelets) and adaptive (T and B lymphocytes) immune cells synthesize several pro- and anti-angiogenic mediators. Moreover, in pre-clinical models, a synergy has been observed between antiangiogenic molecules and immunotherapy. In this review article, we will focus on some angiogenenic and anti-angiogenic molecules properties of immune cells that may be utilized for a potential parmacological use as anti-angiogenic agents in cancer.

Cite this article as:

Ribatti D., Crivellato E. and Vacca A., Inflammation and Antiangiogenesis in Cancer, Current Medicinal Chemistry 2012; 19 (7) . https://dx.doi.org/10.2174/092986712799320655